News Releases

Click here to access press releases from Astellas Pharma Inc. located in Tokyo, Japan.

Month Year

Jul 13, 2005

OSI Pharmaceuticals Announces Tarceva Granted Approval in Canada for the Treatment of Advanced Non-Small Cell Lung Cancer
Jun 27, 2005

OSI Pharmaceuticals Announces that Tarceva-R- Receives Positive Opinion in EU for the Treatment of Patients with Advanced Lung Cancer
Jun 2, 2005

OSI Pharmaceuticals Announces Issuance of Additional U.S. Patent for Tarceva; Extends Patent Exclusivity
May 27, 2005

Astellas and Item File Lawsuit Against Adenoscan® Generic For Patent Infringement in the USA
May 24, 2005

New Studies of Immunosuppressive Regimens Limiting or Avoiding the Use of Steroids Show Excellent Graft Survival in Transplant Recipients on a Prograf®-Based (Tacrolimus) Regimen

One Study of Early Steroid Withdrawal Reduced Cholesterol Levels and Decreased Onset of Post Transplant Diabetes

Show per page

Statements

Careers

Stay Connected

Get only the email alerts you want.

Media Contacts

For media inquiries and reporter requests, please email us at corporate.communications@us.astellas.com.

Our communications team will respond to verified media requests within 24-48 hours as appropriate.

If you are not a reporter and need assistance, please visit our contact us page that includes information for patients, healthcare providers and researchers.

Download Fact Sheet

Sustainability

Investors

Explore U.S. Products

Su	Mo	Tu	We	Th	Fr	Sa

Su	Mo	Tu	We	Th	Fr	Sa

News Releases

You are now leaving XTANDI.com

You are now leaving newsroom.astellas.com.